APA (7th ed.) Citation

DR, B., Y, W., E, T., AA, F., L, L., AT, P., . . . TL, J. (2024). Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and presents therapeutic possibilities in an agent-based model. Frontiers in immunology, 15, 1358019. https://doi.org/10.3389/fimmu.2024.1358019

Chicago Style (17th ed.) Citation

DR, Bergman, Wang Y, Trujillo E, Fernald AA, Li L, Pearson AT, Sweis RF, and Jackson TL. "Dysregulated FGFR3 Signaling Alters the Immune Landscape in Bladder Cancer and Presents Therapeutic Possibilities in an Agent-based Model." Frontiers in Immunology 15 (2024): 1358019. https://doi.org/10.3389/fimmu.2024.1358019.

MLA (9th ed.) Citation

DR, Bergman, et al. "Dysregulated FGFR3 Signaling Alters the Immune Landscape in Bladder Cancer and Presents Therapeutic Possibilities in an Agent-based Model." Frontiers in Immunology, vol. 15, 2024, p. 1358019, https://doi.org/10.3389/fimmu.2024.1358019.